233 related articles for article (PubMed ID: 25216078)
1. A novel functional interplay between Progesterone Receptor-B and PTEN, via AKT, modulates autophagy in breast cancer cells.
De Amicis F; Guido C; Santoro M; Lanzino M; Panza S; Avena P; Panno ML; Perrotta I; Aquila S; Andò S
J Cell Mol Med; 2014 Nov; 18(11):2252-65. PubMed ID: 25216078
[TBL] [Abstract][Full Text] [Related]
2. Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells.
De Amicis F; Guido C; Santoro M; Giordano F; Donà A; Rizza P; Pellegrino M; Perrotta I; Bonofiglio D; Sisci D; Panno ML; Tramontano D; Aquila S; Andò S
Oncotarget; 2016 Sep; 7(36):57955-57969. PubMed ID: 27462784
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
[TBL] [Abstract][Full Text] [Related]
4. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
[TBL] [Abstract][Full Text] [Related]
5. Bergapten drives autophagy through the up-regulation of PTEN expression in breast cancer cells.
De Amicis F; Aquila S; Morelli C; Guido C; Santoro M; Perrotta I; Mauro L; Giordano F; Nigro A; Andò S; Panno ML
Mol Cancer; 2015 Jul; 14():130. PubMed ID: 26148846
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene.
Guido C; Panza S; Santoro M; Avena P; Panno ML; Perrotta I; Giordano F; Casaburi I; Catalano S; De Amicis F; Sotgia F; Lisanti MP; Andò S; Aquila S
Cell Cycle; 2012 Aug; 11(15):2911-21. PubMed ID: 22810004
[TBL] [Abstract][Full Text] [Related]
7. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.
Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G
BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087
[TBL] [Abstract][Full Text] [Related]
8. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
9. Ligand-activated progesterone receptor B activates transcription factor EB to promote autophagy in human breast cancer cells.
Tan S; Bajalovic N; Wong ESP; Lin VCL
Exp Cell Res; 2019 Sep; 382(1):111433. PubMed ID: 31100306
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
11. First trimester human placental factors induce breast cancer cell autophagy.
Epstein Shochet G; Drucker L; Pasmanik-Chor M; Pomeranz M; Fishman A; Tartakover Matalon S; Lishner M
Breast Cancer Res Treat; 2015 Feb; 149(3):645-54. PubMed ID: 25656679
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of autophagy induced by PTEN loss promotes intrinsic breast cancer resistance to trastuzumab therapy.
Ning L; Guo-Chun Z; Sheng-Li A; Xue-Rui L; Kun W; Jian Z; Chong-Yang R; Ling-Zhu W; Hai-Tong L
Tumour Biol; 2016 Apr; 37(4):5445-54. PubMed ID: 26563373
[TBL] [Abstract][Full Text] [Related]
13. STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells.
Nan H; Han L; Ma J; Yang C; Su R; He J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1684-1692. PubMed ID: 29408595
[TBL] [Abstract][Full Text] [Related]
14. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
[TBL] [Abstract][Full Text] [Related]
15. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling.
Yin Y; Wang X; Li T; Ren Q; Li L; Sun X; Zhang B; Wang X; Han H; He Y; Cao Z; Sun X; Zhou Z
Cancer Med; 2020 Feb; 9(4):1544-1552. PubMed ID: 31899608
[TBL] [Abstract][Full Text] [Related]
17. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells.
Yu W; Ni Y; Saji M; Ringel MD; Jaini R; Eng C
Hum Mol Genet; 2017 Apr; 26(7):1365-1375. PubMed ID: 28164237
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors.
Estrella JS; Broaddus RR; Mathews A; Milton DR; Yao JC; Wang H; Rashid A
Arch Pathol Lab Med; 2014 Aug; 138(8):1027-36. PubMed ID: 25076292
[TBL] [Abstract][Full Text] [Related]
19. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
[TBL] [Abstract][Full Text] [Related]
20. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
Zhong T; Xu F; Xu J; Liu L; Chen Y
Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
